Northern Green Canada Inc. (NGC) commissioned Cannabis Research Associates (CRA), in co-operation with their R&D subsidiary company Northern Green Sciences (NGS) to conduct a multi-phase study Cannabis For Opioid Substitution Trial (COST) approved by the Canadian Research Ethics Board (REB) to define common strains of cannabis for patients to use as a replacement for opioids.
November 12, 2018
· 3 min read